Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OGA | O60502 | 1/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | THRB | P10828 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3547731 | 0.95 | OGA (0.32) | OGA | |
| SCHEMBL8533169 | 0.95 | OGA (0.32) | OGA | |
| SCHEMBL11669546 | 0.95 | OGA (0.32) | OGA | |
| SCHEMBL14312202 | 0.88 | ABCB1 (0.32) | OGA | |
| SCHEMBL4617635 | 0.87 | ABCB1 (0.30) | — | |
| SCHEMBL17004686 | 0.87 | — | — | |
| SCHEMBL812463 | 0.84 | ABCB1 (0.31) | — | |
| SCHEMBL813499 | 0.83 | — | — | |
| SCHEMBL9452989 | 0.83 | ABCB1 (0.32) | — | |
| SCHEMBL8151448 | 0.78 | ABCB1 (0.30) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7820142-B2 | Immunogenic glycopeptides, screening, preparation and uses | INSTITUT PASTEUR (FR) | 2010-10-26 | — | — | US | disclosed |
| US-7658929-B2 | Immunogenic glycopeptides, screening, preparation and uses | INSTITUT PASTEUR (FR) | 2010-02-09 | — | — | US | disclosed |
| EP-1343814-B1 | IMMUNOGENIC GLYCOPEPTIDES, SCREENING, PREPARATION AND USES | PASTEUR INSTITUT (FR) | 2009-09-16 | — | — | EP | disclosed |
| US-20080293620-A1 | Immunogenic Glycopeptides for Diagnosing Pathogenic Microorganisms Infections | INSTITUT PASTEUR (FR) | 2008-11-27 | — | — | US | disclosed |
| US-20080233599-A1 | IMMUNOGENIC GLYCOPEPTIDES, SCREENING, PREPARATION AND USES | INSTITUT PASTEUR (FR) | 2008-09-25 | — | — | US | disclosed |
| US-7361348-B2 | Immunogenic glycopeptides, screening, preparation and uses | INSTITUT PASTEUR (FR) | 2008-04-22 | — | — | US | disclosed |
| EP-1810033-A2 | IMMUNOGENIC GLYCOPEPTIDES FOR DIAGNOSING PATHOGENIC MICROORGANISMS INFECTIONS | INSTITUT PASTEUR (FR) | 2007-07-25 | — | — | EP | disclosed |
| WO-2006035317-A2 | IMMUNOGENIC GLYCOPEPTIDES FOR DIAGNOSING PATHOGENIC MICROORGANISMS INFECTIONS | INSTITUT PASTEUR (FR) | 2006-04-06 | — | — | WO | disclosed |
| US-20060067888-A1 | Immunogenic glycopeptides, screening, preparation and uses | INSTITUT PASTEUR (FR) | 2006-03-30 | — | — | US | disclosed |
| US-20040171523-A1 | Immunogenic glycopeptides, screening, preparation and uses | INSTITUT PASTEUR (FR) | 2004-09-02 | — | — | US | disclosed |
| EP-1343814-A2 | IMMUNOGENIC GLYCOPEPTIDES, SCREENING, PREPARATION AND USES | INSTITUT PASTEUR (FR) | 2003-09-17 | — | — | EP | disclosed |
| WO-2002050108-A2 | IMMUNOGENIC GLYCOPEPTIDES, SCREENING, PREPARATION AND USES | INSTITUT PASTEUR (FR) | 2002-06-27 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040171523-A1 | Immunogenic glycopeptides, screening, preparation and uses | CD4, MICA, HLA-DRB1 | OGA 371/4885CYP2D6 1478/4885THRB 1228/4885 |
| US-20060067888-A1 | Immunogenic glycopeptides, screening, preparation and uses | CD14, MICA, HLA-DRB1 | OGA 132/4885CYP2D6 2876/4885THRB 4166/4885 |
| US-20080293620-A1 | Immunogenic Glycopeptides for Diagnosing Pathogenic Microorganisms Infections | CD4, CD14, DNPEP | OGA 186/4885CYP2D6 4226/4885THRB 1659/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.